Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMYD3 | Q9H7B4 | 1/20 | 0.31 |
| ▸ | KDM1A | O60341 | 1/20 | 0.30 |
| ▸ | MAOB | P27338 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12677486 | 0.82 | SMYD3 (0.32) | SMYD3KDM1AMAOB | |
| SCHEMBL23489031 | 0.82 | SMYD3 (0.32) | SMYD3KDM1AMAOB | |
| SCHEMBL31988 | 0.82 | SMYD3 (0.32) | SMYD3KDM1AMAOB | |
| SCHEMBL21799676 | 0.75 | SMYD3 (0.35) | SMYD3 | |
| SCHEMBL18988920 | 0.75 | KDM1A (0.33) | KDM1AMAOB | |
| SCHEMBL21799814 | 0.75 | SMYD3 (0.35) | SMYD3 | |
| SCHEMBL18988922 | 0.75 | KDM1A (0.33) | KDM1AMAOB | |
| SCHEMBL31985 | 0.75 | SMYD3 (0.35) | SMYD3 | |
| Hydrochloric Acid SCHEMBL29696541 | 0.73 | KDM1A (0.32) | KDM1AMAOB | |
| SCHEMBL12465921 | 0.73 | SMYD3 (0.34) | SMYD3KDM1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240066135-A1 | DRUG CONJUGATES AND USES THEREOF | SUPERTRANS MEDICAL LTD (IL) | 2024-02-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240066135-A1 | DRUG CONJUGATES AND USES THEREOF | SLC7A1, ABCB11, SLC1A5 | SMYD3 2112/4885KDM1A 4648/4885MAOB 2140/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.